Does Playing American Football Increase the Risk of Parkinson’s Disease?

Health & Lifestyle
677

Listen to article (english)

Translate to Spanish or other 102 languages!

Playing impact sports such as football come at a high risk of experiencing head trauma. Image for illustration purposes
Playing impact sports such as football come at a high risk of experiencing head trauma. Image for illustration purposes

Medical News Today

- Advertisement -
  • Nearly one million people in the United States and more than 8.5 million worldwide live with Parkinson’s disease.
  • Sports with a high risk of head trauma, such as boxing and soccer, have been associated with an increased risk of Parkinson’s.
  • Now, a study has suggested that American football may also increase the risk by as much as 61%.

According to the World Health OrganizationTrusted Source, the prevalence of Parkinson’s has doubled in the past 25 years. In 2019, the WHO estimated that more than 8.5 millionTrusted Source individuals had the condition. Although the causes are not fully known, researchTrusted Source suggests that head trauma may increase the risk of developing Parkinson’s.

Follow the link below to read he entire article on Medical News Today: 

https://www.medicalnewstoday.com/articles/does-playing-american-football-increase-the-risk-of-parkinsons-disease?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-17&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas Health & Human Services Secures $984M For Texas Hospitals
Next article
$2M for the West Laredo Gateway Community Health Center

More Articles

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.
- Advertisement -